Rhythm Pharmaceuticals (RYTM) Accounts Payables (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Accounts Payables of $12.3 million for Q1 2026, up 3.25% year-over-year from $11.9 million in Q1 2025, and down 11.82% quarter-over-quarter from $13.9 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Accounts Payables (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Accounts Payables for 11 consecutive years, with $12.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 3.25% year-over-year to $12.3 million; the TTM figure through Mar 2026 stood at $12.3 million (up 3.25% YoY), while the FY2025 annual figure was $13.9 million, up 13.13% from the prior year.
- Accounts Payables retreated to $12.3 million in Q1 2026 per RYTM's latest filing, from $13.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $16.0 million in Q2 2025 and bottomed at $3.8 million in Q3 2023.
- Historically, Accounts Payables has averaged $9.1 million across 5 years, with a median of $8.4 million in 2023.
- Annual changes were most pronounced in 2024 — Accounts Payables sank 45.81% — and 2025, when it surged 251.79%.
- Rhythm Pharmaceuticals' Accounts Payables stood at $4.8 million in 2022, then gained by 1.83% to $4.9 million in 2023, then surged by 152.36% to $12.3 million in 2024, then advanced by 13.13% to $13.9 million in 2025, then decreased by 11.82% to $12.3 million in 2026.
- Business Quant data shows RYTM's Accounts Payables at $12.3 million in Q1 2026, $13.9 million in Q4 2025, and $13.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 16.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.17 Mn |
| Mar 31, 2026 | 12.30 Mn |
| Dec 31, 2025 | 13.95 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Jun 30, 2025 | 15.98 Mn |
| Mar 31, 2025 | 11.91 Mn |
| Dec 31, 2024 | 12.33 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 7.55 Mn |
| Dec 31, 2023 | 4.89 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 8.38 Mn |
| Mar 31, 2023 | 13.35 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 4.93 Mn |
| Jun 30, 2022 | 6.01 Mn |
| Mar 31, 2022 | 12.01 Mn |
| Dec 31, 2021 | 5.74 Mn |
| Sep 30, 2021 | 4.61 Mn |